Trial intelligence / Profile preview

Clobetasol propionate shampoo with or without ketoconazole for moderate to severe scalp seborrheic dermatitis

2008-005217-22Phase 3Completed

Sponsor
Galderma
Start
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of clobetasol in seborrheic dermatitis (SD) (3 arms), sponsored by Galderma. Primary endpoint: Percentage change at week 4 in Total Severity Score (TSS). Started Dec 2008; status: completed.

02

Drugs

clobetasol
03

Conditions

seborrheic dermatitis (SD)

Beyond the preview

Go deeper on 2008-005217-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005217-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call